World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics

Abstract

BACKGROUND: Prevalence of allergic diseases in infants, whose parents and siblings do not have allergy, is approximately 10% and reaches 20-30% in those with an allergic first-degree relative. Intestinal microbiota may modulate immunologic and inflammatory systemic responses and, thus, influence development of sensitization and allergy. Probiotics have been reported to modulate immune responses and their supplementation has been proposed as a preventive intervention. OBJECTIVE: The World Allergy Organization (WAO) convened a guideline panel to develop evidence-based recommendations about the use of probiotics in the prevention of allergy. METHODS: We identified the most relevant clinical questions and performed a systematic review of randomized controlled trials of probiotics for the prevention of allergy. We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop recommendations. We searched for and reviewed the evidence about health effects, patient values and preferences, and resource use (up to November 2014). We followed the GRADE evidence-to-decision framework to develop recommendations. RESULTS: Currently available evidence does not indicate that probiotic supplementation reduces the risk of developing allergy in children. However, considering all critical outcomes in this context, the WAO guideline panel determined that there is a likely net benefit from using probiotics resulting primarily from prevention of eczema. The WAO guideline panel suggests: a) using probiotics in pregnant women at high risk for having an allergic child; b) using probiotics in women who breastfeed infants at high risk of developing allergy; and c) using probiotics in infants at high risk of developing allergy. All recommendations are conditional and supported by very low quality evidence. CONCLUSIONS: WAO recommendations about probiotic supplementation for prevention of allergy are intended to support parents, clinicians and other health care professionals in their decisions whether to use probiotics in pregnancy and during breastfeeding, and whether to give them to infants.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 60

1. 1.

   Haahtela T, von Hertzen L, Makela M, Hannuksela M. Allergy Programme Working G: Finnish Allergy Programme 2008–2018–time to act and change the course. Allergy. 2008;63:634-45.

   Not in our library10.1111/j.1398-9995.2008.01712.x

2. 2.

   Prescott SL, Dunstan JA, Hale J, Breckler L, Lehmann H, Weston S, Richmond P. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy. 2005;35:1557-64.

   Not in our library10.1111/j.1365-2222.2005.02376.x

3. 3.

   Arshad SH, Kurukulaaratchy RJ, Fenn M, Matthews S. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest. 2005;127:502-8.

   Not in our library10.1378/chest.127.2.502

4. 4.

   Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis JW, Rigo J, Shamir R, Szajewska H, Turck D. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:465-73.

   Not in our library10.1097/00005176-200411000-00003

5. 5.

   Shreiner A, Huffnagle GB, Noverr MC. The "Microflora Hypothesis" of allergic disease. Adv Exp Med Biol. 2008;635:113-34.

   Not in our library10.1007/978-0-387-09550-9_10

6. 6.

   Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73:444S-50S.

   Not in our library10.1093/ajcn/73.2.444s

7. 7.

   Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, Cocco R, Dreborg S, Goodman R, Kuitunen M, Haahtela T, et al. Clinical use of probiotics in pediatric allergy (CUPPA): A world allergy organization position paper. World Allergy Organ J. 2012;5:148-67.

   Not in our library10.1097/wox.0b013e3182784ee0

8. 8.

   Technological & Commercial Applications of Lactic Acid Bacteria; Health & Nutritional Benefits in Dairy Products [ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf]

   Not in our library

9. 9.

   Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126:S1-58.

   Not in our library10.1016/j.jaci.2010.10.008

10. 10.

    Agostoni C, Decsi T, Fewtrell M, Goulet O, Kolacek S, Koletzko B, Michaelsen KF, Moreno L, Puntis J, Rigo J, et al. Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2008;46:99-110.

    Not in our library10.1097/01.mpg.0000304464.60788.bd

11. 11.

    Schunemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, Ventresca M, Brignardello-Petersen R, Laisaar KT, Kowalski S, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2013;186:E123-142.

    Not in our library10.1503/cmaj.131237

12. 12.

    GRADEpro Guideline Development Tool (G2DT): Brożek J, Nowak A, Kunstman P, Schünemann HJ. (Computer Program) Version 2.xx. (Available from: www.guidelinedevelopment.org). In Book GRADEpro Guideline Development Tool (G2DT): Brożek J, Nowak A, Kunstman P, Schünemann HJ. (Computer Program) Version 2.xx. (Available from: www.guidelinedevelopment.org). (Editor ed.^eds.). City; 2014.

    Not in our library

13. 13.

    Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64:395-400.

    Not in our library10.1016/j.jclinepi.2010.09.012

14. 14.

    Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [www.cochrane-handbook.org]

    Not in our library

15. 15.

    Azad MB, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Becker AB, Friesen C, Abou-Setta AM, Zarychanski R. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ. 2013;347:f6471.

    Not in our library10.1136/bmj.f6471

16. 16.

    Betsi GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol. 2008;9:93-103.

    Not in our library10.2165/00128071-200809020-00002

17. 17.

    Doege K, Grajecki D, Zyriax BC, Detinkina E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood–a meta-analysis. Br J Nutr. 2012;107:1-6.

    Not in our library10.1017/s0007114511003400

18. 18.

    Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can. 2009;31:542-52.

    Not in our library10.1016/s1701-2163(16)34218-9

19. 19.

    Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics. 2013;132:e666-676.

    Not in our library10.1542/peds.2013-0246

20. 20.

    Foolad N, Brezinski EA, Chase EP, Armstrong AW. Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids. JAMA Dermatol. 2013;149:350-5.

    Not in our library10.1001/jamadermatol.2013.1495

21. 21.

    Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008;121:116-121.

    Not in our library10.1016/j.jaci.2007.10.043

22. 22.

    Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach JF, La Vecchia C. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012;23:402-14.

    Not in our library10.1097/ede.0b013e31824d5da2

23. 23.

    Boyle RJ, Ismail IH, Kivivuori S, Licciardi PV, Robins-Browne RM, Mah LJ, Axelrad C, Moore S, Donath S, Carlin JB, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy. 2011;66:509-16.

    Not in our library10.1111/j.1398-9995.2010.02507.x

24. 24.

    Dotterud CK, Storro O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 2010;163:616-23.

    Not in our library10.1111/j.1365-2133.2010.09889.x

25. 25.

    Huurre A, Laitinen K, Rautava S, Korkeamaki M, Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: A double-blind placebo-controlled study. Clin Exp Allergy. 2008;38:1342-8.

    Not in our library10.1111/j.1365-2222.2008.03008.x

26. 26.

    Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, Lee SY, Ahn KM, Ji GE. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21:e386-93.

    Not in our library10.1111/j.1399-3038.2009.00958.x

27. 27.

    Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002;109:119-21.

    Not in our library10.1067/mai.2002.120273

28. 28.

    Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355-60.

    Not in our library10.1016/j.jaci.2012.09.003

29. 29.

    Abrahamsson TR, Jakobsson T, Bottcher MF, Fredrikson M, Jenmalm MC, Bjorksten B, Oldaeus G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174-80.

    Not in our library10.1016/j.jaci.2007.01.007

30. 30.

    Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, Jones RH, Macfarlane TV, Seager AL, Manshian B, et al. Probiotics and atopic ECZEMA: A double-blind randomised controlled trial. Arch Dis Child. 2012;97:A2.

    Not in our library10.1136/archdischild-2012-301885.5

31. 31.

    Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor M, Garaiova I, Plummer SF, Wang D, Morgan G. Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr. 2010;140:483-8.

    Not in our library10.3945/jn.109.117093

32. 32.

    Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet. 2001;357:1076-9.

    Not in our library10.1016/s0140-6736(00)04259-8

33. 33.

    Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869-71.

    Not in our library10.1016/s0140-6736(03)13490-3

34. 34.

    Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121:e850-856.

    Not in our library10.1542/peds.2007-1492

35. 35.

    Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Haahtela T, Savilahti E. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335-41.

    Not in our library10.1016/j.jaci.2008.11.019

36. 36.

    Kukkonen AK, Kuitunen M, Savilahti E, Pelkonen A, Malmberg P, Makela M. Airway inflammation in probiotic-treated children at 5 years. Pediatr Allergy Immunol. 2011;22:249-51.

    Not in our library10.1111/j.1399-3038.2010.01079.x

37. 37.

    Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:192-8.

    Not in our library10.1016/j.jaci.2006.09.009

38. 38.

    Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T, Korpela R, Savilahti E, Vaarala O. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy. 2008;38:611-8.

    Not in our library10.1111/j.1365-2222.2008.02942.x

39. 39.

    Niers L, Martin R, Rijkers G, Sengers F, Timmerman H, van Uden N, Smidt H, Kimpen J, Hoekstra M. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy. 2009;64:1349-58.

    Not in our library10.1111/j.1398-9995.2009.02021.x

40. 40.

    Ou CY, Kuo HC, Wang L, Hsu TY, Chuang H, Liu CA. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: A randomized, double-blind, placebo-controlled trial. Clin Exp Allergy. 2012;42:1386-96.

    Not in our library10.1111/j.1365-2222.2012.04037.x

Cited by papers we hold 11

• Probiotics: mechanism of action, health benefits and their application in food industries · 2023
  Corrected
• Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions · 2021
  No notice
• Emerging Priorities for Microbiome Research · 2020
  No notice
• Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation · 2020
  No notice
• Dysbiosis of the gut and lung microbiome has a role in asthma · 2020
  No notice
• The potential for pre-, pro- and synbiotics in the management of infants at risk of cow's milk allergy or with cow's milk allergy: An exploration of the rationale, available evidence and remaining questions · 2019
  Not checked
• Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture · 2019
  No notice
• Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians · 2018
  No notice
• Diet during pregnancy and infancy and risk of allergic or autoimmune disease: A systematic review and meta-analysis · 2018
  No notice
• The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming · 2017
  No notice
• Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.